En-Cler Biomedical Waste Profile
Key Indicators
- Authorised Capital ₹ 2.65 Cr
as on 07-07-2024
- Paid Up Capital ₹ 2.30 Cr
as on 07-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.63 Cr
as on 07-07-2024
- Revenue -4.00%
(FY 2023)
- Profit -0.70%
(FY 2023)
- Ebitda -0.00%
(FY 2023)
- Net Worth 27.47%
(FY 2023)
- Total Assets 16.01%
(FY 2023)
About En-Cler Biomedical Waste
The Corporate was formerly known as Envision Bio Medical Waste Treatment Private Limited. The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.65 Cr and a paid-up capital of Rs 2.30 Cr.
The company has closed loans amounting to ₹2.63 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rekha Sarvaiya, Nirav Thakkar, Urvashi Thakkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999GJ2012PTC071616
- Company No.
071616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at En-Cler Biomedical Waste?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Sarvaiya  | Director | 20-Apr-2022 | Current |
| Nirav Thakkar | Director | 20-Apr-2022 | Current |
| Urvashi Thakkar | Director | 15-Jun-2015 | Current |
| Archit Shah | Director | 31-Mar-2015 | Current |
Financial Performance of En-Cler Biomedical Waste.
En-Cler Biomedical Waste Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4% decrease. The company also saw a slight decrease in profitability, with a 0.7% decrease in profit. The company's net worth Soared by an impressive increase of 27.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of En-Cler Biomedical Waste?
In 2023, En-Cler Biomedical Waste had a promoter holding of 81.56% and a public holding of 18.44%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
En-Cler Biomedical Waste Management Private LimitedActive 4 years 11 monthsRekha Sarvaiya, Nirav Thakkar and 2 more are mutual person
- En-Passco Waste Management LlpActive 2 years 2 months
Nirav Thakkar and Archit Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Mar 2019 | ₹1.50 Cr | Satisfied |
Others Creation Date: 13 Mar 2019 | ₹1.13 Cr | Satisfied |
How Many Employees Work at En-Cler Biomedical Waste?
En-Cler Biomedical Waste has a workforce of 54 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of En-Cler Biomedical Waste, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped En-Cler Biomedical Waste's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
